Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China
· Delayed Price · Currency is CNY 57.64
-0.57 (-0.98%)
Apr 30, 2026, 9:44 AM CST
SHA:688799 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 7,644 | 6,264 | 3,928 | 4,591 | 2,986 | 3,862 | Upgrade
|
| Market Cap Growth | 105.17% | 59.46% | -14.43% | 53.75% | -22.69% | - | Upgrade
|
| Enterprise Value | 8,108 | 6,320 | 3,696 | 4,184 | 2,376 | 3,094 | Upgrade
|
| Last Close Price | 58.21 | 47.70 | 29.57 | 33.83 | 21.51 | 27.21 | Upgrade
|
| PE Ratio | 33.72 | 26.29 | 23.91 | 21.72 | 16.33 | 24.02 | Upgrade
|
| PS Ratio | 5.08 | 4.16 | 2.78 | 3.20 | 2.31 | 3.37 | Upgrade
|
| PB Ratio | 3.68 | 3.07 | 2.15 | 2.60 | 1.80 | 2.61 | Upgrade
|
| P/TBV Ratio | 4.01 | 3.34 | 2.48 | 2.84 | 2.01 | 2.72 | Upgrade
|
| P/FCF Ratio | - | - | - | 42.24 | 125.46 | 170.68 | Upgrade
|
| P/OCF Ratio | - | 20.87 | 27.62 | 21.41 | 19.18 | 33.66 | Upgrade
|
| EV/Sales Ratio | 5.39 | 4.20 | 2.62 | 2.92 | 1.84 | 2.70 | Upgrade
|
| EV/EBITDA Ratio | - | 26.70 | 17.77 | 15.85 | 11.01 | 16.27 | Upgrade
|
| EV/EBIT Ratio | 33.77 | 38.16 | 26.57 | 20.62 | 14.23 | 19.85 | Upgrade
|
| EV/FCF Ratio | - | - | - | 38.50 | 99.86 | 136.75 | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.24 | 0.07 | 0.01 | - | - | Upgrade
|
| Debt / EBITDA Ratio | 2.94 | 2.10 | 0.57 | 0.06 | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.16 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.22 | 0.14 | -0.30 | -0.41 | -0.42 | -0.51 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.03 | 1.20 | -2.59 | -2.75 | -3.23 | -3.96 | Upgrade
|
| Net Debt / FCF Ratio | -1.67 | -1.29 | 5.89 | -6.69 | -29.33 | -33.30 | Upgrade
|
| Asset Turnover | 0.52 | 0.55 | 0.61 | 0.69 | 0.68 | 0.84 | Upgrade
|
| Inventory Turnover | 1.52 | 1.48 | 1.41 | 1.46 | 1.32 | 1.31 | Upgrade
|
| Quick Ratio | 1.15 | 1.21 | 2.15 | 2.77 | 2.99 | 3.41 | Upgrade
|
| Current Ratio | 2.83 | 2.86 | 3.42 | 4.01 | 4.23 | 4.65 | Upgrade
|
| Return on Equity (ROE) | 11.02% | 11.80% | 7.73% | 11.27% | 11.05% | 15.01% | Upgrade
|
| Return on Assets (ROA) | 3.45% | 3.75% | 3.75% | 6.06% | 5.48% | 7.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.19% | 8.69% | 10.28% | 16.89% | 17.61% | 21.25% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.50% | 6.30% | 6.80% | 11.00% | 9.70% | 10.10% | Upgrade
|
| Earnings Yield | 2.97% | 3.80% | 4.18% | 4.60% | 6.12% | 4.16% | Upgrade
|
| FCF Yield | - | -3.51% | -2.33% | 2.37% | 0.80% | 0.59% | Upgrade
|
| Dividend Yield | 0.74% | - | 1.45% | 1.90% | 2.99% | 1.84% | Upgrade
|
| Payout Ratio | 72.01% | 26.42% | 52.55% | 39.96% | 35.92% | - | Upgrade
|
| Buyback Yield / Dilution | -2.38% | -2.41% | 0.03% | -0.19% | -17.21% | -13.60% | Upgrade
|
| Total Shareholder Return | -1.64% | -2.41% | 1.48% | 1.71% | -14.22% | -11.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.